Actively Recruiting
Mechanisms of Maternal Immune Tolerance in Early Pregnancy
Led by University Hospital, Basel, Switzerland · Updated on 2026-03-04
100
Participants Needed
1
Research Sites
247 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study explores the mechanisms of maternal immune tolerance in early pregnancy by characterizing immune cell profiles and functional pathways during the first trimester. The goal is to identify immunological factors that support healthy gestation and prevent complications such as miscarriages.
CONDITIONS
Official Title
Mechanisms of Maternal Immune Tolerance in Early Pregnancy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Blood will be collected before and during pregnancies or failed implantation conceived through IVF/ICSI treatment and in case of miscarriage
- Participant is 18 years of age or older
- Participant has signed a written informed consent
You will not qualify if you...
- Presence of certain maternal infections: HIV, Hepatitis B, Hepatitis C, or Syphilis
- Use of immunosuppressive medications at the time of blood sample collection
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University Hospital Basel
Basel, Switzerland, 4031
Actively Recruiting
Research Team
U
Ursula Gobrecht-Keller, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here